Pediatric Blood & Cancer: Vol 60, No 9

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Pediatric Blood & Cancer

Journal list menu

Tools

Follow journal

Pediatric Blood & Cancer: Volume 60, Issue 9

Download PDFs

Highlights

Impact of tumor location on medulloblastoma subtyping and treatment (Commentary on teo et al., page xxx)

Cardiotoxicity in childhood cancer survivors: A problem with long-term consequences in need of early detection and prevention

Reviews

Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group

Warfarin pharmacogenomics in children

Priority Report

Implications of Tumor Location on Subtypes of Medulloblastoma

Research Articles

Oncology

PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report

FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway

Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG)

Acute toxicity of proton beam radiation for pediatric central nervous system malignancies

Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma

Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy

Improving the prognosis of pediatric hodgkin lymphoma in developing countries: A moroccan society of pediatric hematology and oncology study

Mental health disparities between hispanic and non-hispanic parents of childhood cancer survivors

Long-term outcome of vincristine–aspirin–ticlopidine (VAT) therapy for vascular tumors associated with kasabach–merritt phenomenon

Hematology

Sickle cell disease related mortality in the United States (1999–2009)

Alloimmunization in sickle cell anemia in the era of extended red cell typing

Acute care of pediatric patients with sickle cell disease: A simulation performance assessment

Transcranial doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge

The palatability and tolerability of deferasirox taken with different beverages or foods

BMT

PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor

Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review

Survivorship

Early Cardiac Outcomes Following Contemporary Treatment for Childhood Acute Myeloid Leukemia: A North American Perspective

Renal function adaptation up to the fifth decade after treatment of children with unilateral renal tumor: A cross-sectional and longitudinal study

Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis

Endothelial function in long-term survivors of childhood acute lymphoblastic leukemia: Effects of a home-based exercise program

Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors

Letters To The Editor

Limited renal prophylaxis in regular plasmatherapy for heritable ADAMTS13 deficiency

Novel frameshift mutations in ADAMTS13 in two families with hereditary thrombotic thrombocytopenic purpura

Abstracts

Abstract

Brief Reports

Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms

Schimke immunoosseous dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child

Absence of epstein–barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies

Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life

High burden of metastases and poor outcome in pelvic PNET

Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma

Successful port-a-cath salvage using linezolid in children with acute leukemia

RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia

Molecular assessment of minimal residual disease in PBSC harvests provides prognostic information in neuroblastoma

Sign up for email alerts

Tools

More from this journal

Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG)